210 related articles for article (PubMed ID: 32269632)
1. Upregulated miR-665 expression independently predicts poor prognosis of lung cancer and facilitates tumor cell proliferation, migration and invasion.
Xia J; Li D; Zhu X; Xia W; Qi Z; Li G; Xu Q
Oncol Lett; 2020 May; 19(5):3578-3586. PubMed ID: 32269632
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of miR-425-5p is associated with poor prognosis and tumor progression in non-small cell lung cancer.
Fu Y; Li Y; Wang X; Li F; Lu Y
Cancer Biomark; 2020; 27(2):147-156. PubMed ID: 31771046
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of miR-518b in non-small cell lung cancer serves as a biomarker and facilitates tumor cell proliferation, migration and invasion.
Zhang X; Hu Y; Gong C; Zhang C
Oncol Lett; 2020 Aug; 20(2):1213-1220. PubMed ID: 32724361
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-1298 is downregulated in non-small cell lung cancer and suppresses tumor progression in tumor cells.
Du Z; Wu J; Wang J; Liang Y; Zhang S; Shang Z; Zuo W
Diagn Pathol; 2019 Dec; 14(1):132. PubMed ID: 31801557
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of miR-1181 in non-small cell lung cancer and its regulatory effect on tumor progression.
Liu F; Ma G; Wang B; Wang X; Huang C
Exp Ther Med; 2021 Nov; 22(5):1284. PubMed ID: 34630639
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-374b-5p Functions as a Tumor Suppressor in Non-Small Cell Lung Cancer by Targeting FOXP1 and Predicts Prognosis of Cancer Patients.
Li J; Zhang X; Tang J; Gong C
Onco Targets Ther; 2020; 13():4229-4237. PubMed ID: 32523358
[TBL] [Abstract][Full Text] [Related]
8. miR-1225-5p inhibits non-small cell lung cancer cell proliferation, migration and invasion, and may be a prognostic biomarker.
Li B; Zhang F; Li H
Exp Ther Med; 2020 Dec; 20(6):172. PubMed ID: 33101465
[TBL] [Abstract][Full Text] [Related]
9. Aberrant expression of miR-4728 in patients with non-small cell lung cancer and its regulatory effects on tumor progression in tumor cells.
Hu Y; Zhang X; Gong C; Li J
Exp Ther Med; 2020 Nov; 20(5):15. PubMed ID: 32934680
[TBL] [Abstract][Full Text] [Related]
10. Clinical Significance and Tumor-Suppressive Function of miR-516b in Nonsmall Cell Lung Cancer.
Zhu J; Zhang Y; Yang X; Jin L
Cancer Biother Radiopharm; 2017 May; 32(4):115-123. PubMed ID: 28514208
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-1301-3p promotes the progression of non-small cell lung cancer by targeting Thy-1 and predicts poor prognosis of patients.
Xu L; Ni N; Gao H; Hu P
Oncol Lett; 2021 Apr; 21(4):327. PubMed ID: 33692859
[TBL] [Abstract][Full Text] [Related]
12. miR-582-5p is a potential prognostic marker in human non-small cell lung cancer and functions as a tumor suppressor by targeting MAP3K2.
Wang LL; Zhang M
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7760-7767. PubMed ID: 30536321
[TBL] [Abstract][Full Text] [Related]
13. MiR-141-3p functions as a tumor suppressor through directly targeting ZFR in non-small cell lung cancer.
Li W; Cui Y; Wang D; Wang Y; Wang L
Biochem Biophys Res Commun; 2019 Feb; 509(3):647-656. PubMed ID: 30611568
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-1296 expression is associated with prognosis and inhibits cell proliferation and invasion by Wnt signaling in non-small cell lung cancer.
Deng H; Xie C; Ye Y; Du Z
Oncol Lett; 2020 Jan; 19(1):623-630. PubMed ID: 31897178
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of microRNA-423-3p indicates poor prognosis and promotes cell proliferation, migration, and invasion of lung cancer.
Wang R; Li G; Zhuang G; Sun S; Song Z
Diagn Pathol; 2019 Jun; 14(1):53. PubMed ID: 31164163
[TBL] [Abstract][Full Text] [Related]
16. miR-4317 suppresses non-small cell lung cancer (NSCLC) by targeting fibroblast growth factor 9 (FGF9) and cyclin D2 (CCND2).
He X; Chen SY; Yang Z; Zhang J; Wang W; Liu MY; Niu Y; Wei XM; Li HM; Hu WN; Sun GG
J Exp Clin Cancer Res; 2018 Sep; 37(1):230. PubMed ID: 30227870
[TBL] [Abstract][Full Text] [Related]
17. Low LINC01272 predicts poor prognosis of non-small cell lung cancer and its biological function in tumor cells by inhibiting miR-1303.
Zhang S; Zhou J
Oncol Lett; 2021 Sep; 22(3):652. PubMed ID: 34386074
[TBL] [Abstract][Full Text] [Related]
18. Upregulated expression of miR-421 is associated with poor prognosis in non-small-cell lung cancer.
Li Y; Cui X; Li Y; Zhang T; Li S
Cancer Manag Res; 2018; 10():2627-2633. PubMed ID: 30147363
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of miR-758 inhibited proliferation, migration, invasion, and promoted apoptosis of non-small cell lung cancer cells by negatively regulating HMGB.
Zhou GH; Lu YY; Xie JL; Gao ZK; Wu XB; Yao WS; Gu WG
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30446524
[TBL] [Abstract][Full Text] [Related]
20. Decreased microRNA-224 and its clinical significance in non-small cell lung cancer patients.
Zhu D; Chen H; Yang X; Chen W; Wang L; Xu J; Yu L
Diagn Pathol; 2014 Nov; 9():198. PubMed ID: 25410592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
